The sustained acoustic medicine treatment reduces the cause of pain, accelerates the healing process, delivers mechanical compression, increases deep circulation, enhances oxygen and nutrient delivery and provides daily therapy multiple hours per day. The technology is proven in over 20 clinical trials supporting the efficacy of treatment.

Having two mutated copies of the TP53 gene - as opposed to a single mutated copy - is associated with worse outcomes in myelodysplastic syndrome and acute myeloid leukemia.

Dr. Mark L. Gordon of Millennium Health Centers, Inc. discusses the science supporting neuroinflammation as a contributing factor to mental illness.

Homecare settings segment size in the cardiac arrhythmia monitoring devices market is predicted to reach USD 950 million by 2026, led by growing awareness about remote patient monitoring devices in developing countries.

Tevogen Bio believes that its highly purified antigen specific T cell investigational therapy holds promise in the treatment of viral infections including COVID-19 and Influenza A

Nathan Diers promoted to Vice President of Product Development

Rallying around Start-Ups struggling in COVID-19 pandemic. MMG - Mike Margiotta Group is a privately owned Consulting Group launching in response to the fallout from the spread of coronavirus infections.

A new study uses large-scale genetic approach to uncover human genes controlling HIV infection.

$450,000 Award from Chan Zuckerberg Initiative is Part of Rare As One Project Investing $13.5 Million to Drive Progress Against Rare Diseases

With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.

New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.

The company will further develop its high-resolution spinal cord stimulation focal pain therapy and perform clinical studies